1

NAB Statement on FCC Regulatory Fees for Fiscal Year 2021

WASHINGTON, D.C. -- In response to an order by the Federal Communications Commission setting regulatory fees for Fiscal Year 2021, the following statement can be attributed to NAB Senior Vice President of Communications Ann Marie Cumming:




1

PILOT Announces Winners of the 2021 Innovation Challenge




1

NAB Presents 2021 Marconi Radio Awards and State of the Industry Address Online




1

2021 BEIT Conference Presentations and Proceedings to Be Released Digitally




1

NAB President and CEO Gordon Smith Delivers 2021 State of the Industry Address

WASHINGTON, D.C. -- NAB President and CEO Gordon Smith delivered a State of the Industry address today. 




1

2021 NAB Marconi Radio Awards Winners Announced




1

PILOT Launches New NEXTGEN TV Fellowship, Introduces 2021 Fellows




1

NAB Show Surpasses 1,000 Exhibitors

Washington, D.C. -- The NAB Show floor will feature some of the world's leading brands and companies, as well as first-time exhibitors and innovation zones showcasing the most cutting-edge technology advancements for media and entertainment. The 2023 NAB Show will run April 15–19 at the Las Vegas Convention Center (LVCC).




1

NAB Show Welcomes More Than 160 Countries to Centennial Celebration

Washington, D.C. -- NAB Show today announced that representatives from more than 160 countries outside the United States have registered to attend the 2023 NAB Show in Las Vegas, April 15-19. As part of its centennial celebration, the 2023 NAB Show aims to share the lasting memories and experiences from international visitors as they reflect on 100 years of innovation.




1

NAB Launches 2023 Congressional PSA Campaign Featuring Over 150 Members of Congress

WASHINGTON, D.C. – The National Association of Broadcasters (NAB) today announced the launch of the 2023 NAB Congressional PSA Campaign, which promotes important messages in local communities across the country. Public service announcements filmed in NAB’s state-of-the-art studio featuring over 150 members of Congress and their families are available to local television and radio stations across the country through their Extreme Reach inbox.




1

NAB Statement on Appeals Court Ordering FCC to Complete 2018 Quadrennial Review

WASHINGTON, D.C. – In response to the U.S. Court of Appeals for the D.C. Circuit providing the Federal Communications Commission 90 days to complete the 2018 quadrennial review or show cause why NAB’s petition for mandamus should be granted, the following statement can be attributed to NAB President and CEO Curtis LeGeyt:




1

Attendance Surpasses 12,000 for NAB Show New York

NEW YORK— Total preliminary registered attendance reached 12,231 for the 2023 NAB Show New York, held October 24-26 at the Javits Center. NAB Show New York is the most efficient and diverse event experience on the East Coast where thousands of content economy professionals reconnect, reevaluate and rediscover ways to get more creative with new-to-market tech and existing tools through exhibits, conferences and networking events. There are more than 225 sessions hosting nearly 300 speakers.




1

Ray Quiñones Joins NAB as Director of Government Relations

Ray Quiñones has joined the National Association of Broadcasters (NAB) as director of Government Relations, effective today. Quiñones will report to Shawn Donilon, executive vice president of Government Relations.




1

Nearly 1,300 NAB Show Exhibitors Showcase Groundbreaking New Products and Technologies

Washington, DC — From early-stage startups and edge-of-the-art media technologies to industry powerhouses debuting boundary-pushing products and technologies, a dynamic roster of nearly 1,300 exhibitors will present the forefront of innovation at the 2024 NAB Show in Las Vegas, April 13-17 (Exhibits April 14-17). With 65,000-70,000 attendees from 160 countries and 575 international exhibitors from 41 countries, NAB Show is the world’s largest marketplace featuring advanced technologies and solutions from the latest gear to generative AI to ATSC 3.0 and beyond, exploring the impact of the newest tech on storytelling, business models and society as a whole.




1

How To Write A Guitar Solo Pt. 1

I keep receiving questions about writing songs and/or guitar solos, and I get a lot of difficult questions in my inbox ;)

I was recently asked to do a series of videos, outlining how I go about writing a guitar solo, with effects and so forth. I decided to accept the challenge, though this is a very difficult thing to do. To turn on a camera, suddenly become inventive, and explain what is going on is a sure pathway to a headache, and today I definitely have one, but none the less - I delivered.

So in this next 3 videos I explain how I go about song writing and adding a guitar solo. I explained this to the best of my capabilities, using some common sense, and a little improvisation, but there is a lot of good information in this video series, and I do reveal some of my secrets that normally I wouldn't.

Hope this helps you out a lot and please enjoy - it took me 6 hours to make these 3 videos. Parts 2 and 3 are on the way.







  • how to write a guitar solo

1

Creative Guitar Soloing Lesson 1 - From Notes To Solos




1

Inside the 2021 Rabbath Institute LA

The pedagogical influence of Francois Rabbath on the double bass world has been tremendous. Once seen as a dramatic departure from traditional bass technique, the Rabbath approach has become mainstream and perhaps the most commonly used method for young bassists. The story behind the Rabbath Institute Cielito De Jesus started the Rabbath Institute Los Angeles […]




1

APO-OLMESARTAN/AMLODIPINE/HCTZ 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack (olmesartan medoxomil)

Manufacturing




1

APO-PRAZOSIN prazosin (as hydrochloride) 1mg tablet blister pack (prazosin hydrochloride)

Manufacturing




1

SEVREDOL morphine sulfate pentahydrate 10mg tablet blister pack (morphine sulfate pentahydrate)

Commercial Changes / Commercial viability




1

ESTRADOT 100 estradiol 100 microgram transdermal drug delivery system sachet (estradiol)

Manufacturing




1

CAVERJECT IMPULSE alprostadil 10microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device (alprostadil)

Manufacturing




1

PRASUGREL LUPIN prasugrel 10 mg film-coated tablet blister pack (prasugrel)

Manufacturing




1

BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial (cerliponase alfa)

Manufacturing




1

TACROGRAF tacrolimus 1 mg capsule bottle (tacrolimus monohydrate)

Manufacturing




1

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule (bupivacaine hydrochloride monohydrate)

Manufacturing




1

ACETYLCYSTEINE-LINK INJECTION acetylcysteine 2g/10mL concentrated injection ampoule (acetylcysteine)

Transport / Logistic issues / Storage capacity issues




1

Ezetast 10/10 ezetimibe and atorvastatin (as calcium trihydrate) 10 mg/10 mg tablets blister pack (atorvastatin calcium trihydrate)

Manufacturing




1

FLUOROURACIL ACCORD fluorouracil 5000 mg/100 mL injection vial (fluorouracil)

Manufacturing




1

ADRENALINE-LINK 1:1,000 1mg/1mL adrenaline (epinephrine) acid tartrate injection BP ampoule (adrenaline (epinephrine) acid tartrate)

Manufacturing




1

DBL HEPARIN SODIUM 5000IU/1mL (porcine mucous) injection BP ampoule (heparin sodium)

Unexpected increase in consumer demand




1

APO-TOPIRAMATE topiramate 100 mg tablet blister pack (topiramate)

Manufacturing




1

MOXICAM meloxicam 15 mg capsule blister pack (meloxicam)

Manufacturing




1

OXYNORM LIQUID oxycodone hydrochloride 1mg/mL oral liquid bottle (oxycodone hydrochloride)

Unexpected increase in consumer demand




1

ARIANNA 1 anastrozole 1 mg film-coated tablet blister pack (anastrozole)

Manufacturing




1

CISATRACURIUM JUNO cisatracurium (as besilate) 10mg/5mL Solution for Injection ampoule (cisatracurium besilate)

Transport / Logistic issues / Storage capacity issues




1

APX-AMOXICILLIN/CLAVULANIC ACID 500/125 amoxicillin 500 mg (as trihydrate) & clavulanic acid 125 mg (as potassium) tablet strip pack (potassium clavulanate)

Commercial Changes / Commercial viability




1

APX-AMOXICILLIN/CLAVULANIC ACID 500/125 amoxicillin 500 mg (as trihydrate) & clavulanic acid 125 mg (as potassium) tablet strip pack (amoxicillin trihydrate)

Commercial Changes / Commercial viability




1

AVSARTAN HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack (irbesartan)

Manufacturing




1

AVSARTAN HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack (hydrochlorothiazide)

Manufacturing




1

HYPNOVEL midazolam 5mg/1mL (as hydrochloride) injection ampoule (midazolam)

Manufacturing




1

BICILLIN L-A benzathine benzylpenicillin tetrahydrate 1,200,000 Units / 2.3 mL suspension for injection pre-filled syringe with needle (benzathine benzylpenicillin tetrahydrate)

Manufacturing




1

EZEMICHOL ezetimibe 10mg tablet blister pack (ezetimibe)

Manufacturing




1

APO-ATOMOXETINE atomoxetine (as hydrochloride) 100 mg capsule blister (atomoxetine hydrochloride)

Manufacturing




1

APO-LEVETIRACETAM levetiracetam 1000 mg film coated tablet blister pack (levetiracetam)

Manufacturing




1

GAMINE XR galantamine (as hydrobromide) 16mg modified release capsules blister pack (galantamine hydrobromide)

Manufacturing




1

TRILEPTAL oxcarbazepine 150mg tablet film coated blister pack (oxcarbazepine)

Manufacturing




1

CERVARIX human papillomavirus vaccine types 16 and 18 [recombinant, AS04 adjuvanted] suspension for injection pre-filled syringe (HPV Type 18 L1 Protein)

Commercial Changes / Commercial viability




1

CERVARIX human papillomavirus vaccine types 16 and 18 [recombinant, AS04 adjuvanted] suspension for injection pre-filled syringe (HPV Type 16 L1 Protein)

Commercial Changes / Commercial viability




1

Regulation (EU) 2024/1781 of the European Parliament and of the Council of 13 June 2024 Establishing a Framework for the Setting of Ecodesign Requirements for Sustainable Products

Room 30, Parliament Buildings



  • Windsor Framework Democratic Scrutiny Committee